Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Act-3
Active Ingredient: Ibuprofen 200mg
Dosage Form: Liquid filled capsule
New Zealand Sponsor: Wyeth Consumer Healthcare A Division of Wyeth (NZ) Limited
Manufacturer: Cardinal Health Australia 401 Pty Ltd trading as R.P.Scherer, Braeside, Victoria, Australia
Product: Raptiva
Active Ingredient: Efalizumab 125mg
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Genentech Inc, South San Francisco, California, United States of America
Laboratoires Serono SA, Aubonne, Switzerland
Dated this 14th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).